The US Food and Drug Administration (FDA) has cleared for marketing the first screening test for severe combined immunodeficiency (SCID) in newborns. The EnLite Neonatal TREC Kit, manufactured by ...

WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc., announced the launch of its EONIS™ Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt ...

PerkinElmer, Inc., a global leader in improving the health and safety of people and the environment, has introduced the first commercially available screening test for Severe Combined Immunodeficiency ...

Martha Jane Anderson buried two blue-eyed infant sons before she learned the truth about her chromosomes: Any boys born in her family would have a 50 percent chance of entering the world without a ...

Finer-grained newborn screening "This discovery has direct implications for SCID newborn screening, for counseling on stem cell transplants and treatment of severe inflammatory complications," says ...

DECATUR, Ill. (AP) — Illinois newborn babies are now being screened for a rare disease called severe combined immunodeficiency. The (Decatur) Herald and Review reported Sunday (bit.ly/1jcWEqy) that ...

Newborn screening searches for genetic markers in blood or heel prick samples to detect health issues in infants, enabling crucial early intervention that improves long-term outcomes. The advent of ...

Skin cancer is typically caused by damage to the skin's cells from ultraviolet radiation. But a recent case study has just shed light on another potential cause: human papillomavirus. Early results ...

Researchers from Nijmegen and Newcastle discovered a new genetic mutation leading to severe combined immune deficiency disorder (SCID). It’s the first time a mutation in the proteasome, a molecular ...

Early results from a study of newborn screening methods show that DNA analysis picks up many more preventable or treatable serious health conditions than standard newborn screening and is favored by ...

For both inherited conditions, immediate detection is critical to advancing a positive outcome. For SMA, disease modifying therapies exist to stop progression of disease, and for SCID, immunoglobulin ...